Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.80% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 5.19% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | 5.84% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | -281.76% |
| Mar 31, 2024 | 18.96% |
| Dec 31, 2023 | 17.05% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 3.03% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 11.98% |
| Sep 30, 2022 | 152.91% |
| Jun 30, 2022 | 44.72% |
| Mar 31, 2022 | 41.56% |
| Dec 31, 2021 | -20.37% |
| Sep 30, 2021 | 104.17% |
| Jun 30, 2021 | -27.74% |
| Mar 31, 2021 | 48.97% |
| Dec 31, 2020 | 89.73% |
| Sep 30, 2020 | 61.37% |
| Jun 30, 2020 | 92.03% |
| Mar 31, 2020 | 108.23% |
| Dec 31, 2019 | 79.58% |
| Sep 30, 2019 | 31.12% |
| Jun 30, 2019 | 47.30% |
| Mar 31, 2019 | 50.02% |
| Dec 31, 2018 | 128.47% |
| Sep 30, 2018 | 38.34% |
| Jun 30, 2018 | 46.73% |
| Mar 31, 2018 | 124.87% |
| Dec 31, 2017 | 83.08% |
| Sep 30, 2017 | -1,579.40% |
| Jun 30, 2017 | -725.44% |
| Mar 31, 2017 | 479.85% |
| Dec 31, 2016 | 2.03% |
| Sep 30, 2016 | -6.12% |
| Jun 30, 2016 | -5.62% |
| Mar 31, 2016 | 0.40% |
| Dec 31, 2015 | 17.61% |
| Sep 30, 2015 | -80.09% |
| Jun 30, 2015 | -64.44% |
| Mar 31, 2015 | -30.84% |
| Dec 31, 2014 | -28.77% |
| Sep 30, 2014 | -26.00% |
| Mar 31, 2014 | 87.48% |
| Dec 31, 2013 | 3.20% |
| Sep 30, 2013 | 3.23% |
| Jun 30, 2013 | 1.73% |
| Mar 31, 2013 | -6.45% |
| Dec 31, 2012 | -22.09% |
| Sep 30, 2012 | 43.86% |
| Jun 30, 2012 | 39.93% |
| Mar 31, 2012 | 36.44% |